循環器ジャーナル69巻1号

2021年01月発行

特集 これからの高齢者診療—循環器医が人生100年時代にどう向き合うか？ Ⅱ．高齢者に対するintensive care

―紙上ディベート―弁膜症：内科的立場

著者： 白井伸一¹ 磯谷彰宏¹

所属機関： ¹小倉記念病院循環器内科

ページ範囲：P.74 - P.79

Point
・TAVIは今後低リスクを含めて広く適応となっていくと思われるが，弁の長期耐久性を含めてハートチームでのディスカッションで適応を決定すべきものと思われる．
・僧帽弁においては，カテーテル治療において様々なデバイスが出現してくるが，その適応としては僧帽弁閉鎖不全症の病態にて使い分けていくことが重要である．
・三尖弁閉鎖不全症に対してもカテーテル治療が適応となるが，最も重要なことは治療の至適時期を判断すること，そして三尖弁逆流の新たな定義を構築していくことと思われる．

参考文献

1) Cribier A, Eltchaninoff H, Bash A, et al:Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis:first human case description. Circulation 106:3006-3008, 2002

2) Smith CR, Leon MB, Mack MJ, et al:PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187-2198, 2011

3) Leon MB, Smith CR, Mack M, et al:Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597-1607, 2010

4) Leon MB, Smith CR, Mack MJ, et al:Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 374:1609-1620, 2016

5) Adams DH, Popma JJ, Reardon MJ, et al:Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370:1790-1798, 2014

6) Reardon MJ, Van Mieghem NM, Popma JJ, et al:Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 376:1321-1331, 2017

7) Mack MJ, Leon MB, Thourani VH, et al:Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 380:1695-1705, 2019

8) Popma JJ, Deeb GM, Yakubov SJ, et al:Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 380:1706-1715, 2019

9) van Gils L, Clavel M-A, Vollema EM, et al:Prognostic implications of moderate aortic stenosis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol:69:2383-2392, 2017

10) Tarantini G, Buja P, Scognamiglio R, et al:Aortic valve replacement in severe aortic stenosis with left ventricular dysfunction:determinants of cardiac mortality and ventricular function recovery. Eur J Cardiothorac Surg 24:879-885, 2003

11) Taniguchi T, Morimoto T, Shiomi H, et al:Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis. J Am Coll Cardiol 66:2827-2838, 2015

12) Kang DH, Park SJ, Lee SA, et al:Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis. N Engl J Med 382:111-119, 2020

13) Mack MJ, Leon MB, Smith CR, et al:5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis（PARTNER 1）:a randomised controlled trial. Lancet 385:2477-2484, 2015

14) Makkar RR, Thourani VH, Mack MJ, et al:Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement. N Engl J Med 382:799-809, 2020

15) Mack MJ, Leon MB:Two-year Clinical and Echocardiographic Outcomes from the Partner 3 Low-risk Randomized Trial. ACC 2020 in CHICAGO

16) Capodanno D, Petronio AS, Prendergast B, et al:Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves:a consensus statement from the European Association of Percutaneous Cardiovascular Interventions（EAPCI）endorsed by the European Society of Cardiology（ESC）and the European Association for Cardio-Thoracic Surgery（EACTS）. Eur Heart J 38:3382-3390, 2017

17) Herrmann HC, Daneshvar SA, Fonarow GC, et al:Prosthesis-Patient Mismatch in Patients Undergoing Transcatheter Aortic Valve Replacement:From the STS/ACC TVT Registry. J Am Coll Cardiol 72:2701-2711, 2018

18) Otto CM, Lind BK, Kitzman DW, et al:Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 341:142-147, 1999

19) Hahn RH, Zamorano JL:The need for a new tricuspid regurgitation grading scheme. Eur Heart J Cardiovasc Imaging 18:1342-1343, 2017